Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Program for Retail Investors and Benefits with TiiCKER
Innovative test technology stock leverages artificial intelligence-powered TiiCKER platform to engage, verify and reward shareholders
SALT LAKE CITY, December 7, 2021 / PRNewswire / – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company that develops and manufactures advanced diagnostic technology used in more than 50 countries, announced a partnership with TiiCKER™; a consumer shareholder loyalty platform, to increase its connection with retail investors. Co-Diagnostics partners with TiiCKER to reach new and existing investors, verify its shareholders and stock market benefits, and connect with retail investors interested in learning more about their world-class testing services and technologies via www.TiiCKER.com/CODX.
“We have a great story of technology and growth to tell, but previously it was impossible for us to reach retail investors let alone verify their ownership to engage shareholders and reward their loyalty,” said Dwight Egan, Managing Director of Co-Diagnostics. “With the TiiCKER platform and app, we can now connect directly with retail investors, increase our awareness among this long-standing loyal audience, and show them how much we appreciate their support. “
TiiCKER has created a new industry – direct shareholder marketing – by partnering with innovative public companies and leading brands to create and grow the premier platform for shareholder retention and engagement.
“Retail investors are looking to discover new ideas and exciting stocks, and shareholders, like ordinary consumers, want to be rewarded for their loyalty,” said Jeff Lambert, founder and CEO of TiiCKER. “Co-Diagnostics rightly values this investor audience and its scale – 130 million individual investors in the United States alone – as an untapped audience as it seeks to grow the CODX profile to match its performance. . Likewise, their B2B business model, but highly relevant technology helping people in over 50 countries fight disease and diagnose genetic markers is an ideal fit for TiiCKER and our ability to reach retail investors. “
Investors who register and verify ownership on TiiCKER can qualify for CODX branded apparel, including a premium cotton blend hoodie, sport wicking polo shirt and baseball cap. To view the CODX Shareholder Store ™ or to claim stock benefits, please visit tiicker.com/CODX.
About Co-Diagnostics, Inc .:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets new advanced diagnostic technology. The Company’s technology is used for tests designed using the detection and / or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in sectors other than infectious diseases and to authorize the use of these tests to specific customers.
Launched in 2020, TiiCKER has invented verified stock benefits and direct marketing to shareholders through its web and iOS mobile application software platform that offers consumers and investors a revolutionary way to engage with the brands they love. For America’s 130 million retail investors, TiiCKER provides unique access to shareholder benefits, commission-free exchanges and personalized content to help shareholder consumers discover and connect with the companies and brands they love. For its public company brand partners, TiiCKER enables companies to engage, verify and reward consumer shareholders to better serve and understand their investors and to maximize the Shareholder Lifetime Value ™ of their retail investors. For more information, please visit TiiCKER.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/creator-of-covid-19-and-global-molecular-testing-products-co-diagnostics-inc-launches-retail-investor-and-perks-program- with-tiicker-301439580.html
SOURCE Co-Diagnostics, Inc.